Medicare limits coverage of controversial Alzheimer's drug to those in clinical trials - 1breakingne
2022-04-08 15 Dailymotion
Medicare will restrict coverage of the controversial and costly Alzheimer's drug Aduhelm to those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced Thursday.
